🇺🇸 FDA
Patent

US 7371821

Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7371821 (Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K48/00